Total Funding
92
58
Total FundingPost-IPO Equity raised
Growth Score
-4 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
54485
Ovid Therapeutic's purpose is to solve intractable medical problems.
- Petra Kaufmann: Chief Medical OfficerPast Role: Affinia Therapeutics, Chief Medical Officer
- Jeremy Levin: Co-founderPast Role: Ovid Therapeutics, Chairperson and CEO
About the Company
Ovid is a pure play neurology company focused on rare and orphan diseases of the brain. They were founded in 2014 to leverage recent advances in science and medicine to find optimal therapies. They seek to identify and develop late stage, de-risked medicines with significant potential.
Their rationale for developing these medicines is based on
key insights from their scientific founders and confirmed in discussions with leading experts in the field. Their products are protected by strong intellectual property. They apply the most efficient processes to bring safe and effective therapies to patients.
They are based in New York City but have collaborators and are working with patients across the United States and the globe.
